These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 21502903

  • 1. AIDS morbidity and mortality in Brazilian children before and after highly active antiretroviral treatment implementation: an assessment of regional trends.
    Ramos AN, Matida LH, Hearst N, Heukelbach J.
    Pediatr Infect Dis J; 2011 Sep; 30(9):773-7. PubMed ID: 21502903
    [Abstract] [Full Text] [Related]

  • 2. Mortality in Brazilian children with HIV/AIDS: the role of non-AIDS-related conditions after highly active antiretroviral therapy introduction.
    Ramos AN, Matida LH, Hearst N, Heukelbach J.
    AIDS Patient Care STDS; 2011 Dec; 25(12):713-8. PubMed ID: 21688987
    [Abstract] [Full Text] [Related]

  • 3. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM, Ramos Amador JT, Fernández de Miguel S, González Tomée MI, Rojo Conejo P, Ferrnado Vivas P, Clemente Vivas J, Ruiz Contreras J, Nogales Espert A.
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [Abstract] [Full Text] [Related]

  • 4. Progression of HIV infection in the post-HAART era among a cohort of HIV+ Greek haemophilia patients.
    Katsarou O, Touloumi G, Antoniou A, Kouramba A, Hatzakis A, Karafoulidou A.
    Haemophilia; 2005 Jul; 11(4):360-5. PubMed ID: 16011588
    [Abstract] [Full Text] [Related]

  • 5. AIDS mortality before and after the introduction of highly active antiretroviral therapy: does it vary with socioeconomic group in a country with a National Health System?
    Borrell C, Rodríguez-Sanz M, Pasarín MI, Brugal MT, García-de-Olalla P, Marí-Dell'Olmo M, Caylà J.
    Eur J Public Health; 2006 Dec; 16(6):601-8. PubMed ID: 16698886
    [Abstract] [Full Text] [Related]

  • 6. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
    Ives NJ, Gazzard BG, Easterbrook PJ.
    J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
    [Abstract] [Full Text] [Related]

  • 7. Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
    Kapogiannis BG, Soe MM, Nesheim SR, Sullivan KM, Abrams E, Farley J, Palumbo P, Koenig LJ, Bulterys M.
    Pediatrics; 2008 May; 121(5):e1229-39. PubMed ID: 18450865
    [Abstract] [Full Text] [Related]

  • 8. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.
    Louie JK, Hsu LC, Osmond DH, Katz MH, Schwarcz SK.
    J Infect Dis; 2002 Oct 01; 186(7):1023-7. PubMed ID: 12232845
    [Abstract] [Full Text] [Related]

  • 9. Is it possible to reduce AIDS deaths without reinforcing socioeconomic inequalities in health?
    Antunes JL, Waldman EA, Borrell C.
    Int J Epidemiol; 2005 Jun 01; 34(3):586-92. PubMed ID: 15737970
    [Abstract] [Full Text] [Related]

  • 10. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
    Wong KH, Chan KC, Lee SS.
    Clin Infect Dis; 2004 Sep 15; 39(6):853-60. PubMed ID: 15472819
    [Abstract] [Full Text] [Related]

  • 11. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR, Kapogiannis BG, Soe MM, Sullivan KM, Abrams E, Farley J, Palumbo P, Koenig LJ, Bulterys M.
    Pediatrics; 2007 Jul 15; 120(1):100-9. PubMed ID: 17606567
    [Abstract] [Full Text] [Related]

  • 12. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival.
    Diamond C, Taylor TH, Aboumrad T, Anton-Culver H.
    Cancer; 2006 Jan 01; 106(1):128-35. PubMed ID: 16329140
    [Abstract] [Full Text] [Related]

  • 13. Universal decline in mortality in patients with advanced HIV-1 disease in various demographic subpopulations after the introduction of HAART in Hong Kong, from 1993 to 2002.
    Chan KC, Wong KH, Lee SS.
    HIV Med; 2006 Apr 01; 7(3):186-92. PubMed ID: 16494633
    [Abstract] [Full Text] [Related]

  • 14. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
    Viani RM, Araneta MR, Deville JG, Spector SA.
    Clin Infect Dis; 2004 Sep 01; 39(5):725-31. PubMed ID: 15356789
    [Abstract] [Full Text] [Related]

  • 15. The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy.
    d'Arminio Monforte A, Sabin CA, Phillips A, Sterne J, May M, Justice A, Dabis F, Grabar S, Ledergerber B, Gill J, Reiss P, Egger M, Antiretroviral Therapy Cohort Collaboration.
    Arch Intern Med; 2005 Feb 28; 165(4):416-23. PubMed ID: 15738371
    [Abstract] [Full Text] [Related]

  • 16. AIDS in Brazilian children: history, surveillance, antiretroviral therapy, and epidemiologic transition, 1984-2008.
    Ramos AN, Matida LH, Hearst N, Heukelbach J.
    AIDS Patient Care STDS; 2011 Apr 28; 25(4):245-55. PubMed ID: 21413856
    [Abstract] [Full Text] [Related]

  • 17. Clinical manifestations of treatment-naive patients with acquired immunodeficiency syndrome and responses to highly active antiretroviral therapy in the Taipei Veterans General Hospital: a 5-year prospective study.
    Hsu SF, Yang SP, Chan YJ, Wang YW.
    J Microbiol Immunol Infect; 2011 Jun 28; 44(3):198-203. PubMed ID: 21524614
    [Abstract] [Full Text] [Related]

  • 18. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
    Ortega KL, Vale DA, Magalhães MH.
    J Oral Pathol Med; 2009 Jul 28; 38(6):489-94. PubMed ID: 19453845
    [Abstract] [Full Text] [Related]

  • 19. Causes of the decline in AIDS deaths, United States, 1995-2002: prevention, treatment or both?
    Holtgrave DR.
    Int J STD AIDS; 2005 Dec 28; 16(12):777-81. PubMed ID: 16336756
    [Abstract] [Full Text] [Related]

  • 20. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.
    Antinori A, Larussa D, Cingolani A, Lorenzini P, Bossolasco S, Finazzi MG, Bongiovanni M, Guaraldi G, Grisetti S, Vigo B, Gigli B, Mariano A, Dalle Nogare ER, De Marco M, Moretti F, Corsi P, Abrescia N, Rellecati P, Castagna A, Mussini C, Ammassari A, Cinque P, d'Arminio Monforte A, Italian Registry Investigative NeuroAIDS.
    Clin Infect Dis; 2004 Dec 01; 39(11):1681-91. PubMed ID: 15578371
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.